Navigation Links
Barby K. Siegel Joins Zeno Group as Chief Executive Officer
Date:10/7/2009

NEW YORK, Oct. 7 /PRNewswire/ -- Zeno Group, a Daniel J. Edelman, Inc. communications firm, today named Barby K. Siegel as chief executive officer. Siegel joins Zeno from Ogilvy Public Relations, where she was managing director of global consumer marketing. Lynn Hanessian, who has served as Zeno's CEO since October 2007, is returning to Edelman to establish and lead Edelman Bio, a full service science and biomedical communications business.

With revenues of $10 million, Zeno has 55 employees in four U.S. offices - New York, Chicago, Los Angeles, and Washington, D.C. - representing clients including AstraZeneca, Craftsman, Evenflo, Kia Motors America, Pizza Hut, Schering-Plough, Turtle Wax, and Wyeth. The firm focuses on Consumer, Corporate, Digital, Health and Public Affairs.

"Barby is a creative and proven leader who has demonstrated her ability to grow business globally," said Richard Edelman, president and chief executive officer of Daniel J. Edelman, Inc. "Her extensive background in brand marketing - particularly in consumer, technology and health - will help continue to drive Zeno's success. I worked closely with Barby for 10 years at Edelman and am thrilled to have her return to the DJE family of companies."

"Lynn has done a superb job of leading Zeno, and her deep experience in the health arena makes her a natural fit to create a dream team of emerging science and medical issues strategists to establish a new global medical communications group," said Edelman. "We look forward to her return to Edelman to undertake her next career challenge."

Siegel will lead Zeno from the firm's New York office - reporting to Richard Edelman, and will work closely with the Zeno senior team: Phil Armstrong, COO (New York); Lisa Robinson, chief creative officer and managing director (Los Angeles); Heather Gartman, managing director (DC); Grant Deady, managing director (Chicago); and Andrea Morgan, managing director
'/>"/>

SOURCE Daniel J. Edelman, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory
2. Sanford Rose Associates Joins the International Executive Search Federation
3. Christopher Brennan Joins PharmaNet Development Group as General Counsel
4. Richard Gephardt Joins Leading Innovators in Washington State to Call for Greater Focus on Policies to Boost Economy and Maintain U.S. Competitiveness in Medical Science and Innovation
5. John J. Young, Jr. Joins SRI Board of Directors
6. Veteran Intellectual Property Team Joins Brown Rudnick
7. Elkan Gamzu, Ph.D. Joins Hygeia Therapeutics Board of Directors as Chair
8. Elsevier Joins InChI Trust as a Charter Member
9. Thomson Joins Brooks Kushman; Strengthens Los Angeles Presence
10. Miami LASIK Laser Eye Surgery, Cataract Surgery, Refractive Surgeon Expert Dr. William Trattler Joins Select Eye Surgeons in Trusted LASIK Surgeons Directory
11. Mark W. Parrish Joins Mylans Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  Orexigen Therapeutics, Inc. (Nasdaq: OREX ) ... of Outstanding Issues (LOI) from the European Medicines Agency,s ... the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone sustained ... candidate being evaluated for weight loss. The ... were adequately addressed by the Company based in part ...
(Date:7/30/2014)... PARK, Md. , July 30, 2014 /PRNewswire-USNewswire/ ... biological components to interrogate biology, but such devices ... biology. As such, researchers have ... for in vitro metabolic engineering to ... on a chip. New devices are envisioned to ...
(Date:7/30/2014)... July 30, 2014  AtheroNova Inc. (OTCBB: AHRO), ... development of compounds to safely regress atherosclerotic plaque ... that its partner, CardioNova, has accomplished first dosing ... with AtheroNova,s lead compound, AHRO-001.  This Phase 1b ... Phase 1 safety trial completed in February 2014, ...
(Date:7/30/2014)... NCERC at Southern Illinois University Edwardsville ... on corn stover pretreatment methods at a U.S. ... D.C. , “Arun’s selection for presentation at ... to the success of our postdoctoral fellowship program,” ... foresight and vision of SIUE and the Illinois ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... Calif., March 30 TorreyPines Therapeutics, Inc. (Nasdaq: ... District Court of the Southern District of New York ... of Axonyx Inc. ("Axonyx") against Axonyx and several of ... in 2006. The plaintiffs alleged that the defendants made ...
... March 30 BioMedical Enterprises, Inc. (BME), a rapidly ... of orthopaedic memory metal implants, announced today that it ... Sales and Marketing. BME specializes in nitinol implants ... ends together to promote bone union. The ...
... Stem Cell Trial to Show Dose-related Significant Improvement in ... Amorcyte, Inc. (Amorcyte) today announced data from its ... product for the treatment of damaged heart muscle following ... between cell dose and biologic effect. This is the ...
Cached Biology Technology:Stockholder Suits Related to TorreyPines Therapeutics, Inc. Dismissed 2BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing 2Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session 2Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session 3Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session 4
(Date:7/30/2014)... A team of biologists, led by Clemson University associate ... marine pest that will pave the way for novel ... bio-adhesives for medical and industrial applications. , The team,s ... examined the last larval stage of barnacles that attaches ... natural, possibly polymeric material that acts as an underwater ...
(Date:7/30/2014)... Press Limited today announced an across-the-board increase in ... The 2013 InCites Journal Citation Reports (Thomson Reuters, ... Biochemical Journal , Essays in Biochemistry , ... Reports all received increases in their Impact ... Society and published by Portland Press Limited. , ...
(Date:7/30/2014)... A professor from Wayne State University,s College of ... National Science Foundation for the project, "Nanoparticle-directed synthesis ... National Science Foundation, nanotechnology is the creation and ... novel properties and functions. A major bottleneck in ... methods that connect different functional materials into one ...
Breaking Biology News(10 mins):Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... and statistically significant improvements in clinical measures of ... the Etiology, Pathogenesis and Treatment of Parkinson's Disease ... positive interim results in patients with Parkinson's disease. ... statistically significant improvement in motor function on the ...
... discovered how a small molecule of RNA called microRNA ?a ... a key protein involved in the early development of heart ... the journal Nature, may aid scientists in their understanding of ... a heart cell, as well as offer researchers a way ...
... Paxinos and Dr Yuri Koutcherov of the Spinal Injuries ... Institute have been awarded ~$200,000 by the Christopher Reeve ... the rat spinal cord over the next two years. ... visit to Australia in 2003 and was impressed with ...
Cached Biology News:Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 2Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 3Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 4Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 5Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease 6MicroRNA tweaks protein that controls early heart development 2MicroRNA tweaks protein that controls early heart development 33D Atlas Will Help Navigate The Spinal Cord 2
GFX PCR DNA,Gel Band Purif,100, 1 EA. Category: Nucleotide Sample Handling....
Full service including gene cloning, protien expression and purification of 1 liter culture....
Superior homology search software - in all the flavours of blast, with increased sensitivity and speed...
Protein 3D structure prediction, via threading. Easy to use....
Biology Products: